Ratings by Morgan Stanley (Chris Yu)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/19/2026 | Zenas Biopharma | ZBIO | New Coverage | Equalweight (N/A) |
24.84 (28.33) |
14.05% | Details | |
| 10/19/2026 | Lakefront Biotherapeutics | LKFT | New Coverage | Equalweight (N/A) |
29.90 (30.54) |
2.14% | Details | |
| 10/19/2026 | Incyte | INCY | New Coverage | Equalweight (N/A) |
113.07 (116.11) |
2.69% | Details | |
| 10/19/2026 | Evommune Inc | EVMN | New Coverage | Overweight (N/A) |
5.17 (5.49) |
6.19% | Details |
